Loading…
Loading…
TELIF does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for TELIF and 80,000+ other tickers.
See exactly how TELIF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for TELIF and 80,000+ other tickers.
Telescope Innovations Corp. is a chemical technology firm dedicated to creating synthetic methods for producing pharmaceutical compounds. These compounds are specifically developed for use in treating mental health conditions. The company's main operational base is located in Vancouver, Canada.
Vancouver, British Columbia--(Newsfile Corp. - August 19, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) (the "Company" or "Telescope"), a leading developer of Physical AI systems, including Self-Driving Laboratories, and enabling technologies and services for the global pharmaceutical and high-value chemical industries, is pleased to announce the appointment of Dr. Neil Lewis to its Board of Directors (the "Board"), effective August 19, 2026. Dr. Lewis received his PhD in chemistry from the Polytechnic of Wales in the UK and did his postdoctoral fellowship at the National Institutes of Health (NIH) in the USA.
Vancouver, British Columbia--(Newsfile Corp. - July 14, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a leading developer of intelligent automation and advanced chemical manufacturing technologies, announces that Ali Pejman has resigned from the Company's Board of Directors ("Board"), effective as of the date of this press release. Henry Dubina, CEO, stated, "On behalf of the Board and management, I would like to thank Ali for his commitment and the thoughtful guidance he has provided during an important period in the Company's growth.
The Company will use the conference to advance commercial discussions around Self-Driving Labs, automated sampling systems, and lithium sulfide materials licensing Vancouver, British Columbia--(Newsfile Corp. - June 23, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a developer of intelligent automation and advanced chemical manufacturing technologies, is pleased to announce that it will be attending the Fastmarkets Global Lithium, Battery & Critical Materials conference in Las Vegas, Nevada from June 23-25, 2026. The conference is one of the sector's leading annual meeting points for participants across the lithium, battery materials, and broader critical minerals value chain, and Telescope will use the event to expand commercial discussions in three strategic areas: Self-Driving Laboratories ("SDLs"), automated sampling systems, and licensing opportunities for the Company's lithium sulfide manufacturing process.
Year-to-date revenues are 80% higher than comparative values for previous fiscal year Vancouver, British Columbia--(Newsfile Corp. - June 16, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE:J4U) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended May 31, 2026 (Q3 FY2026). The Company generated revenues of approximately $2.1 million during this period, driven by a combination of contract services and Self-Driving Lab ("SDL") projects, with an adjusted EBITA loss of $1.1 million.
Vancouver, British Columbia--(Newsfile Corp. - June 11, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a leading developer of intelligent automation and advanced chemical manufacturing technologies, is pleased to announce it will be presenting at the Planet MicroCap Las Vegas 2026 conference on Wednesday, June 17th, 2026. At Planet MicroCap, Dr. Jeffrey Sherman will provide an update on Telescope's business including its DirectInject-LC™ reaction sampling products, a newly announced technology development collaboration with AGI SDA to develop next-generation automated chemistry reactors (see news release dated March 16, 2026), and the Company's growing roster of Self-Driving Lab deployments.